Rangering i aksjer
#24574
CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell... CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell sheet technology. The company is deeply involved in the research, development, and market introduction of advanced cell-sheet medicine products. Its innovations encompass epithelial cell sheets for repairing the esophagus, as well as both regenerated cartilage sheets and chondrocyte sheets aimed at addressing knee osteoarthritis. Beyond its therapeutic pipeline, CellSeed manufactures and distributes a range of specialized cell cultureware. This includes UpCell, a temperature-responsive cultureware vital for cell-sheet engineering; RepCell, another temperature-sensitive product designed for efficient cell collection; and HydroCell, distinguished by its low cell-binding properties. The firm also provides supporting equipment, such as ThermoPlate III, a heating element constructed from transparent glass, and cellZscope, an automated system for real-time cell monitoring. Additionally, CellSeed offers contract development and manufacturing services. Founded in 2001, the company's main operations are situated in Tokyo, Japan.
Handel CellSeed Inc. (7776)
Pris 7776 pris med markedsverdi på B
Markedsverdi av CellSeed Inc.(7776)
Markedsverdi: $59.10M
Per August 2026 har CellSeed Inc. en markedsverdi på $59.10M. Dette gjør CellSeed Inc. til det 24574th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for CellSeed Inc. fra 2010 til 2026
7776 sammenlignet med topp 5 mest populære stocks
| Pris på 7776 |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.225T
|
+8,842,330.34%
|
|
|
|
|
$4.563T
|
+7,721,332.04%
|
|
|
|
|
$4.157T
|
+7,035,123.75%
|
|
|
|
|
$3.588T
|
+6,071,895.18%
|
|
|
|
|
$2.785T
|
+4,712,669.07%
|
